CORC  > 湖南大学
Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity
Gu, Zili; Wang, Qingjie; Shi, Yanbin; Huang, Yi; Zhang, Jing; Zhang, Xinke; Lin, Guimei
刊名JOURNAL OF CONTROLLED RELEASE
2018
卷号Vol.286页码:369-380
关键词Nanotechnology Liposome Docetaxel PD-L1 Immunochemotherapy
ISSN号0168-3659
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5458925
专题湖南大学
作者单位1.Shandong Univ, Sch Pharmaceut Sci, 44 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China
2.Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250012, Shandong, Peoples R China
3.Qilu Univ Technol, Shandong Acad Sci, Sch Mech & Automot Engn, Jinan 250353, Shandong, Peoples R China
4.Jiangxi Univ Tradit Chinese Med, Minist Educ, Key Lab Modern Preparat TCM, Nanchang 330004, Jiangxi, Peoples R China
5.Shandong Univ, Sch Pharmaceut Sci, Drug Screening Unit Platform, Jinan 250012, Shandong, Peoples R China
推荐引用方式
GB/T 7714
Gu, Zili,Wang, Qingjie,Shi, Yanbin,et al. Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity[J]. JOURNAL OF CONTROLLED RELEASE,2018,Vol.286:369-380.
APA Gu, Zili.,Wang, Qingjie.,Shi, Yanbin.,Huang, Yi.,Zhang, Jing.,...&Lin, Guimei.(2018).Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity.JOURNAL OF CONTROLLED RELEASE,Vol.286,369-380.
MLA Gu, Zili,et al."Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity".JOURNAL OF CONTROLLED RELEASE Vol.286(2018):369-380.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace